Patents by Inventor Scott A. Beers

Scott A. Beers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9065063
    Abstract: Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1?,2?-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting diode devices comprising these compounds are also described.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: June 23, 2015
    Assignee: Universal Display Corporation
    Inventors: David B. Knowles, Chun Lin, Peter Borden MacKenzie, Jui-Yi Tsai, Robert W. Walters, Scott A. Beers, Cory S. Brown, Walter H. Yeager
  • Publication number: 20150018549
    Abstract: Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1?,2?-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting diode devices comprising these compounds are also described.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 15, 2015
    Applicant: Universal Display Corporation
    Inventors: David B. KNOWLES, Chun Lin, Peter Borden Mackenzie, Jui-Yi Tsai, Robert W. Walters, Scott A. Beers, Cory S. Brown, Walter H. Yeager
  • Patent number: 8889864
    Abstract: Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1?,2?-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting diode devices comprising these compounds are also described.
    Type: Grant
    Filed: May 15, 2014
    Date of Patent: November 18, 2014
    Assignee: Universal Display Corporation
    Inventors: David B. Knowles, Chun Lin, Peter Borden MacKenzie, Jui-Yi Tsai, Robert W. Walters, Scott A. Beers, Cory S. Brown, Walter H. Yeager
  • Patent number: 8766529
    Abstract: Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1?,2?-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting diode devices comprising these compounds are also described.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: July 1, 2014
    Assignee: Universal Display Corporation
    Inventors: David B. Knowles, Chun Lin, Peter Borden MacKenzie, Jui-Yi Tsai, Robert W. Walters, Scott A. Beers, Cory S. Brown, Walter H. Yeager
  • Patent number: 8691988
    Abstract: Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1?,2?-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting diode devices comprising these compounds are also described.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: April 8, 2014
    Assignee: Universal Display Corporation
    Inventors: David B. Knowles, Chun Lin, Peter Borden Mackenzie, Jui-Yi Tsai, Robert W. Walters, Scott A. Beers, Cory S. Brown, Walter H. Yeager
  • Patent number: 8119621
    Abstract: This invention is directed to a tetrahydro-cyclopentyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Grant
    Filed: July 15, 2010
    Date of Patent: February 21, 2012
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Fina Liotta, Mingde Xia, Michael P. Wachter, Scott A. Beers
  • Publication number: 20110073849
    Abstract: Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1?,2?-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting diode devices comprising these compounds are also described.
    Type: Application
    Filed: October 20, 2010
    Publication date: March 31, 2011
    Inventors: David B. KNOWLES, Chun Lin, Peter Borden MacKenzie, Jui-Yi Tsai, Robert W. Walters, Scott A. Beers, Cory S. Brown, Walter H. Yeager
  • Patent number: 7915415
    Abstract: Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1?,2?-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting diode devices comprising these compounds are also described.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: March 29, 2011
    Assignee: Universal Display Corporation
    Inventors: David B. Knowles, Chun Lin, Peter Borden MacKenzie, Jui-Yi Tsai, Robert W. Walters, Scott A. Beers, Cory S. Brown, Walter H. Yeager
  • Publication number: 20100279991
    Abstract: This invention is directed to a tetrahydro-cyclopentyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Application
    Filed: July 15, 2010
    Publication date: November 4, 2010
    Inventors: Fina Liotta, Mingde Xia, Michael P. Wachter, Scott A. Beers
  • Patent number: 7790718
    Abstract: This invention is directed to a tetrahydro-cyclopentyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
    Type: Grant
    Filed: September 22, 2006
    Date of Patent: September 7, 2010
    Assignee: Janssen Pharmaceutica NV
    Inventors: Fina Liotta, Mingde Xia, Michael P. Wachter, Scott A. Beers
  • Patent number: 6521655
    Abstract: This invention relates to a series of substituted imidazoles of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention inhibit the production of a number of inflammatory cytokines, and are useful in the treatment of diseases associated with overproduction of inflammatory cytokines.
    Type: Grant
    Filed: November 3, 2000
    Date of Patent: February 18, 2003
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Scott A. Beers, Elizabeth A. Malloy, Michael P. Wachter, Wei Wu
  • Patent number: 6214830
    Abstract: This invention relates to a series of substituted imidazoles of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention inhibit the production of a number of inflammatory cytokines, and are useful in the treatment of diseases associated with overproduction of inflammatory cytokines.
    Type: Grant
    Filed: April 20, 1999
    Date of Patent: April 10, 2001
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Scott A. Beers, Elizabeth A. Malloy, Michael P. Wachter, Wei Wu
  • Patent number: 6040320
    Abstract: This invention relates to substituted imidazoles of Formula I ##STR1## pharmaceutical compositions containing them, methods of using them and intermediates useful in their manufacture. The compounds of the invention modulate the production of a number of inflammatory cytokines, and are useful in the treatment of diseases associated with the production of inflammatory cytokines.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: March 21, 2000
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Scott A. Beers, Elizabeth A. Malloy, Michael P. Wachter, Wei Wu
  • Patent number: 5965583
    Abstract: This invention relates to a series of substituted imidazoles of Formula I ##STR1## pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention inhibit the production of a number of inflammatory cytokines, and are useful in the treatment of diseases associated with overproduction of inflammatory cytokines.
    Type: Grant
    Filed: April 17, 1998
    Date of Patent: October 12, 1999
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Scott A. Beers, Elizabeth A. Malloy, Michael P. Wachter, Wei Wu